This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

5 Rocket Stocks to Buy After Last Week's Bounce

Abbott Laboratories

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

The last few years have brought big changes for Abbott Laboratories ( ABT), the biggest being the spinoff of the firm's pharmaceutical business into AbbVie ( ABBV). Yanking the lucrative pharma segment out of Abbott's results provided investors with a much more distilled view of the firm's actual business and gave management a serious goal of shoring up its profitability in the very near-term. Pharma was a hugely profitable crutch for ABT, but its absence will ultimately make the firm a lot more competitive.

>>3 Big Stocks on Traders' Radars

The new Abbott manufactures medical devices, nutritional products, diagnostic equipment and some generic drugs. To be sure, none of those are lackluster businesses to be in, but Abbott's over-reliance on its pharmaceutical segment has shown through. On the flip side, however, Abbott is now spared from the patent cliff that held a gun to the firm's head (and stock valuation) for the last several years, which is a plus.

Abbott still has some attractive cost cutting opportunities in the near-term, as it better integrates its existing product portfolio. Powerhouse offerings such as Xience stents and high-margin nutritional brands generate plenty of free cash flow, and the firm is already much leaner after applying its spin-off proceeds to its debt load. Shorter-term, rising analyst sentiment in shares is our reason for tacking ABT to the top of our Rocket Stock list.

2 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
ABT $47.37 0.00%
CA $32.52 0.00%
NOC $165.71 0.00%
PCLN $1,237.48 0.00%
TRI $39.27 0.00%


DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs